Article
“Same day” vitrectomy to treat endophthalmitis in the course of anti-VEGF treatment for AMD can save the eye and restore visual acuity
Search Medline for
Authors
Published: | June 13, 2018 |
---|
Outline
Text
Goal: To present effects of long-term anti-VEGF (Vascular Endothelial Growth Factor) treatment in eyes after vitrectomy for endophthalmitis in neovascular age related macular degeneration.
Methods: Core vitrectomy, with intravitreal vancomycin was performed. Spectral domain optical coherence tomography was performed monthly both before and after surgery in the follow- up mode. Anti-VEGF injections were continued after surgery.
Results: Eight eyes were included in this study. Final mean visual acuity at the end of follow up (12-84 months) was statistically indifferent from visual acuity on the visit just before endophthalmitis (p=0.69). The mean frequency of injections after surgery did not significantly differ from the presurgical scheme of treatment (p=0.97).
Conclusion: Early vitrectomy for endophthalmitis enables continuation of anti-VEGF injections and does not influence the frequency of injections. This treatment results in satisfactory visual acuity in the long term. Early intervention is safe and might be recommended even for patients with visual acuity better than light perception.